PRF Technologies Ltd. (PRFX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $2.69. It has a SharesGrow Score of 21/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Valuation: PRFX trades at a trailing Price-to-Earnings (P/E) of -0.1 (S&P 500 average ~25).
Financials: revenue is $17,000, -100%/yr average growth. Net income is $5M (loss), growing at +1.5%/yr. Net profit margin is -28458.8% (negative). Gross margin is -4864.7% (-4947.3 pp trend).
Balance sheet: total debt is $21,000 against $9M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 1.78 (strong liquidity). Debt-to-assets is 0.2%. Total assets: $12M.
Analyst outlook: 0 / 1 analysts rate PRFX as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 30/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).
